Postdoctoral Research Fellow

Lavanya  Choppavarapu

Postdoctoral Research Fellow

Molecular Medicine

Mentor:  Dr. Victor Jin

Phone:  2108634383



2017 Ph.D. National Institute of mental health and neurosciences (NIMHANS)
2009 MSc (Biotechnology) Bangalore University
2007 BSc (Biotechnology) Sri Venkateswara University


1. Lavanya C, Venkataswamy MM, Sibin MK, Srinivas Bharath MM, Chetan GK. Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells. Cytotechnology. 2018, 70(4):1143-1154. 

2.Lavanya C, Sibin MK, Srinivas Bharath MM, Manoj MJ, Venkataswamy MM, Bhat DI, Narasinga Rao KV, Chetan GK. RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells. Cytotechnology. 2016, 68(6):2311-2321. 

3. Jeru-Manoj Manuel, Debarati Ghosh, Narasinga Rao KVL , Sibin M K, Venkatesh HN , Lavanya Ch, Arati S, Dhananjaya I Bhat, Srinivas Bharath MM, Chetan GK, Role of Concurrent Methylation Pattern of MGMT, TP53 and CDKN2A Genes in the Prognosis of High Grade Glioma, J Carcinog Mutagene. 2016, 7:1.

4. Sibin M K, ChLavanya, Dhananjaya I Bhat, NarasingaRao, Geethashree N, Vibhuti W, Chetan G K, CD133 and BMI1 expressions and its prognostic role in primary glioblastoma, Journal of Genetics. 2015, 94(4):689-96.

5. Sibin M K, Dhananjaya I Bhat, ChLavanya, Arati S and Chetan GK, Over-expression and lack of copy number variation in BMI-1 gene in Human glioma from Indian Population. Oncology letters.  2015, 10(5):3318-3322.

6. Sibin M K, Dhananjaya I Bhat, K V L NarasingaRao, ChLavanya, G K Chetan , CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high grade glioma, Tumor Biol. 2015, 36(10):7607-14.

7. Sibin M K Dhananjaya I. Bhat , Ch Lavanya , M. Jeru Manoj , S. Aakershita G. K. Chetan, CDKN2A exon-wise deletion status and novel somatic mutations in Indian glioma patients. Tumor Biol. 2014, 35:1467–1472.